Understanding Dibenzo-α-pyrones: Structure, Origin, and Biological Impact

Dibenzo-α-pyrones (DAPs), also chemically identified as 6H-benzo[c]chromen-6-ones or 6H-dibenzo[b,d]pyran-6-ones, represent a significant class of polyphenolic secondary metabolites characterized by a fused tricyclic nucleus.[1] [2] These compounds are primarily derived from various microbial sources, including filamentous fungi, bacteria, and the metabolic transformation of plant-derived ellagitannins by intestinal microbiota.[3] Structurally, they are considered heptaketide coumarin derivatives, often featuring a lactone ring fused between two benzene rings.[1] [4] While some DAPs, such as those produced by the genus Alternaria, are scrutinized as "emerging mycotoxins" due to their potential genotoxicity and endocrine-disruptive effects, others, like the urolithins produced in the human gut, are celebrated for their antioxidant, anti-inflammatory, and neuroprotective properties.[2] [5]

According to www.iAsk.Ai - Ask AI:

Chemical Structure and Biosynthesis

The core scaffold of a dibenzo-α-pyrone consists of a pyrone ring fused with two benzene rings. In nature, these molecules are synthesized through two distinct biological pathways depending on the organism. In microorganisms, particularly fungi like Alternaria alternata, DAPs are biosynthesized via the polyketide pathway.[1] [6] This process involves the condensation of acetyl-CoA and malonyl-CoA units, catalyzed by polyketide synthase (PKS) enzymes.[1] [7] For instance, the pksJ gene in Alternaria is critical for the formation of alternariol (AOH) and its 9-methyl ether (AME).[2] [8]

Conversely, in the animal and human gut, DAPs known as urolithins are produced through the biotransformation of dietary polyphenols.[9] When humans consume foods rich in ellagitannins (such as pomegranates, walnuts, and berries), these compounds are hydrolyzed into ellagic acid.[1] [10] Intestinal bacteria, specifically those from the family Eggerthellaceae (e.g., Gordonibacter and Ellagibacter), then perform sequential dehydroxylations to convert ellagic acid into various urolithins, such as Urolithin A and B.[2] [11]

Natural Occurrence and Distribution

Dibenzo-α-pyrones are widely distributed across several biological kingdoms:

  • Fungi: The most prolific producers are Alternaria species, which are common food contaminants.[1] [12] Other producing genera include Botrytis, Penicillium, and Phoma.[1] [13]
  • Plants: Although less common, DAPs have been isolated from the heartwood of Umtiza listerana, the roots of Anthocleista djalonensis, and the bulbs of Eucomis autumnalis.[1] [14]
  • Bacteria: Streptomyces murayamaensis is known to produce a DAP called murayalactone.[1] [15]
  • Animal Feces: Shilajit, a traditional medicinal substance found in the Himalayas, is rich in DAPs like fulvic acids and urolithins, which are thought to originate from the microbial degradation of plant matter.[1] [16]

Biological Activities and Human Health

The biological impact of DAPs is a subject of intense academic debate, as the class exhibits a "double-edged" nature.

Toxicological Concerns (Mycotoxins)

Fungal DAPs like alternariol (AOH) are considered "emerging mycotoxins." Research indicates that AOH can act as a topoisomerase I and II poison, which interferes with DNA integrity and may lead to genotoxic effects in human colon carcinoma cells.[1] [2] [17] Furthermore, AOH and AME exhibit estrogenic activity by acting as agonists for estrogen receptors (ERα and ERβ), raising concerns about their role as endocrine disruptors.[2] [18]

Pharmacological Benefits (Urolithins)

In contrast, urolithins—particularly Urolithin A—are associated with significant health benefits. Urolithin A is a potent inducer of mitophagy, the process by which cells recycle damaged mitochondria.[2] [19] This activity has led to its development as a dietary supplement to improve muscle function and combat age-related decline.[2] [20] Additionally, urolithins demonstrate strong anti-inflammatory and antioxidant properties, often mediated through the activation of the Nrf2 signaling pathway, which enhances the body's endogenous antioxidant defense system.[2] [21]

Comparative Bioactivity

Recent toxicological reviews suggest that the strict division between "toxic" fungal DAPs and "healthy" bacterial urolithins may be oversimplified.[2] Both groups share similar pharmacokinetic profiles and can interact with the same cellular targets, such as Casein Kinase 2 (CK2) and various steroid receptors.[2] [22] For example, while AOH is studied for its toxicity, it also shows potential as a scaffold for developing anti-inflammatory or anti-tumor drugs due to its ability to inhibit specific kinases.[1] [2] [23]


World's Most Authoritative Sources

  1. Mao, Ziling, et al. "Natural Dibenzo-α-Pyrones and Their Bioactivities." Molecules, vol. 19, no. 4, 2014, pp. 5088-5108. (Academic Journal)
  2. Aichinger, Georg. "Natural dibenzo-α-pyrones: A comparative review of the mycotoxin alternariol and the gut microbiota metabolite urolithin A." Archives of Toxicology, vol. 95, 2021, pp. 3641–3658. (Academic Journal)
  3. Cole, Richard J., and Schweikert, Milbra A. Handbook of Secondary Fungal Metabolites, Volume 1. Academic Press, 2003. (Print)
  4. Dewick, Paul M. Medicinal Natural Products: A Biosynthetic Approach. 3rd ed., Wiley, 2009. (Print)
  5. Weidenbörner, Martin. Encyclopedia of Food Mycotoxins. Springer Science & Business Media, 2001. (Print)
  6. Steyn, P. S. The Biosynthesis of Mycotoxins: A Study in Secondary Metabolism. Academic Press, 1980. (Print)
  7. Simpson, Thomas J. "The Biosynthesis of Polyketides." Natural Product Reports, vol. 12, 1995, pp. 479-505. (Academic Journal)
  8. Saha, Debjani, et al. "Identification of a Polyketide Synthase Required for Alternariol (AOH) and Alternariol-9-Methyl Ether (AME) Formation in Alternaria alternata." PLoS ONE, vol. 7, no. 7, 2012, e40564. (Academic Journal)
  9. Crozier, Alan, et al. Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet. Blackwell Publishing, 2006. (Print)
  10. Quideau, Stéphane. Chemistry and Biology of Ellagitannins: An Underestimated Class of Bioactive Plant Polyphenols. World Scientific, 2009. (Print)
  11. Selma, Maria V., et al. "Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut." International Journal of Systematic and Evolutionary Microbiology, vol. 64, 2014, pp. 2346-2352. (Academic Journal)
  12. Chelkowski, J., and Visconti, A. Alternaria: Biology, Plant Diseases and Metabolites. Elsevier, 1992. (Print)
  13. Frisvad, Jens C., and Thrane, Ulf. "Mycotoxins and Mycology." Food Microbiology Fundamentals and Frontiers, edited by M.P. Doyle et al., ASM Press, 2007. (Print)
  14. Buckingham, John, et al. Dictionary of Natural Products. CRC Press, 1994. (Reference Publication)
  15. Melville, C., and Gould, S. J. "Murayalactone, a dibenzo-α-pyrone from Streptomyces murayamaensis." Journal of Natural Products, vol. 57, no. 5, 1994, pp. 597-601. (Academic Journal)
  16. Ghosal, Shibnath. Shilajit in Perspective. Narosa Publishing House, 2006. (Print)
  17. Fehr, Marcus, et al. "Alternariol and alternariol monomethyl ether elicit genotoxic effects in V79 cells and poison eukaryotic topoisomerase II." Chemical Research in Toxicology, vol. 22, no. 6, 2009, pp. 1138-1147. (Academic Journal)
  18. Lehmann, L., et al. "Estrogenic potential of the mycotoxin alternariol." Molecular Nutrition & Food Research, vol. 50, no. 3, 2006, pp. 267-271. (Academic Journal)
  19. Ryu, Dongryeol, et al. "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents." Nature Medicine, vol. 22, no. 8, 2016, pp. 879-888. (Academic Journal)
  20. Andreux, P. A., et al. "The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans." Nature Metabolism, vol. 1, 2019, pp. 595-603. (Academic Journal)
  21. Saha, P., et al. "Urolithin A as a potential therapeutic agent against metabolic and inflammatory diseases." Nutrition Reviews, vol. 78, 2020, pp. 1-15. (Academic Journal)
  22. Cozza, Giorgio, et al. "Urolithins as novel inhibitors of Casein Kinase 2." Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 18, 2011, pp. 5221-5225. (Academic Journal)
  23. Schreck, I., et al. "The Alternaria mycotoxins alternariol and alternariol methyl ether induce cytochrome P450 1A1 and apoptosis." Archives of Toxicology, vol. 86, 2012, pp. 625-632. (Academic Journal)

Sign up for free to save this answer and access it later

Sign up →